A healthcare company based out of North Carolina is turning heads so far during Tuesday’s session after the company announced that it plans to submit its Dordaviprone for...

To read the full story on AllPennyStocks.com, click here.

Chimerix (NASDAQ:CMRX)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Chimerix
Chimerix (NASDAQ:CMRX)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Chimerix